CN116568286A - 水性组合物 - Google Patents

水性组合物 Download PDF

Info

Publication number
CN116568286A
CN116568286A CN202180059043.5A CN202180059043A CN116568286A CN 116568286 A CN116568286 A CN 116568286A CN 202180059043 A CN202180059043 A CN 202180059043A CN 116568286 A CN116568286 A CN 116568286A
Authority
CN
China
Prior art keywords
aqueous composition
mass
salts
acid
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180059043.5A
Other languages
English (en)
Chinese (zh)
Inventor
久保大空
林纱衣子
喜多亚希子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohto Pharmaceutical Co Ltd
Original Assignee
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co Ltd filed Critical Rohto Pharmaceutical Co Ltd
Publication of CN116568286A publication Critical patent/CN116568286A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202180059043.5A 2020-07-30 2021-07-30 水性组合物 Pending CN116568286A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-129730 2020-07-30
JP2020129730 2020-07-30
PCT/JP2021/028441 WO2022025281A1 (ja) 2020-07-30 2021-07-30 水性組成物

Publications (1)

Publication Number Publication Date
CN116568286A true CN116568286A (zh) 2023-08-08

Family

ID=80036439

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180059043.5A Pending CN116568286A (zh) 2020-07-30 2021-07-30 水性组合物

Country Status (9)

Country Link
US (1) US20230285564A1 (https=)
EP (1) EP4176881A4 (https=)
JP (1) JPWO2022025281A1 (https=)
KR (1) KR20230047401A (https=)
CN (1) CN116568286A (https=)
AU (1) AU2021318237A1 (https=)
CA (1) CA3190313A1 (https=)
TW (1) TW202220659A (https=)
WO (1) WO2022025281A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
EP4674401A3 (en) * 2019-12-27 2026-02-25 Rohto Pharmaceutical Co., Ltd Container accommodating an aqueous ophthalmic composition comprising delgocitinib
AU2021318236A1 (en) * 2020-07-30 2023-03-09 Rohto Pharmaceutical Co., Ltd. Aqueous composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102006872A (zh) * 2008-02-19 2011-04-06 马韦尔生命科学有限公司 含有吡啶酚衍生物的眼科制剂
CN105636590A (zh) * 2013-10-21 2016-06-01 日本烟草产业株式会社 眼病的治疗剂或预防剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011225626A (ja) * 2001-02-01 2011-11-10 Rohto Pharmaceutical Co Ltd 点眼剤
CA2615108A1 (en) * 2005-07-13 2007-01-18 Santen Pharmaceutical Co., Ltd. Preservative composition for ophthalmic use
KR101454674B1 (ko) * 2006-03-17 2014-10-27 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물
WO2008093358A2 (en) * 2007-01-29 2008-08-07 Sun Pharmaceutical Industries Limited Aqueous topical solution containing olopatadine
HK1251223A1 (en) 2015-07-07 2019-01-25 Japan Tobacco, Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
KR102702286B1 (ko) 2016-12-21 2024-09-04 니뽄 다바코 산교 가부시키가이샤 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 공결정
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102006872A (zh) * 2008-02-19 2011-04-06 马韦尔生命科学有限公司 含有吡啶酚衍生物的眼科制剂
CN105636590A (zh) * 2013-10-21 2016-06-01 日本烟草产业株式会社 眼病的治疗剂或预防剂

Also Published As

Publication number Publication date
JPWO2022025281A1 (https=) 2022-02-03
EP4176881A4 (en) 2024-07-31
EP4176881A1 (en) 2023-05-10
KR20230047401A (ko) 2023-04-07
TW202220659A (zh) 2022-06-01
AU2021318237A1 (en) 2023-03-09
WO2022025281A1 (ja) 2022-02-03
CA3190313A1 (en) 2022-02-03
US20230285564A1 (en) 2023-09-14

Similar Documents

Publication Publication Date Title
JP7224390B2 (ja) アトロピン含有水性組成物
CN116568286A (zh) 水性组合物
CN116568285A (zh) 水性组合物
JP2021046394A (ja) ブリモニジンとチモロールとを含む、緑内障罹患患者における眼圧を下降させるための組成物
JP2025019313A (ja) 涙液分泌促進用眼科組成物
CN103608000B (zh) 含有透明质酸或其盐以及丙二醇的滴眼液
JP5834427B2 (ja) ソフトコンタクトレンズへの吸着抑制方法
HK40091721A (zh) 水性组合物
JP5753958B2 (ja) 澄明な水性液剤
HK40091389A (zh) 水性组合物
JP2019123755A (ja) 水性組成物
WO2013147000A1 (ja) ２－アミノ－３－（４－ブロモベンゾイル）フェニル酢酸含有水性組成物
CN105555268A (zh) 阴离子性软隐形眼镜用眼科用组合物
HK40066213A (zh) 泪液分泌促进用眼科组合物
HK40003059B (zh) 含有阿托品的水性组合物
CN112007031A (zh) 眼用制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40091721

Country of ref document: HK